MEP Jerković presses Brussels to match cancer science with access

EU PERSPECTIVES - Europe is facing a cancer paradox. Breakthroughs keep coming, targeted therapies, Nobel Prize-winning immunotherapies, a new wave of advanced treatments such as antibody-drug conjugates (ADCs), bispecific antibodies and CAR-T cell therapies, but patients' chances of survival still depend on where they live. Up to 200,000 deaths a year could be avoided if outcomes matched the best-performing countries, according to a new EU-wide comparison of cancer care. Read more

Romana Jerković at SANT Committee meeting © European Union 2025 – Source: EP, Photo: Alain Rolland